Clinicopathological review of ocular surface squamous neoplasia in Malawi

British Journal of Ophthalmology

Volumn 97, Issue 8, 2013, Pages 961-964

  Tiong, T ^a   Borooah, Shyamanga ^a   Msosa, J ^b   Dean, W ^c   Smith, C ^a   Kambewa, E ^c   Kiire, C ^d   Zondervan, M ^e   Aspinall, P ^f   Dhillon, B ^a,f  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Kamazu Central Hospital   (Malawi)

^c Nkhoma Hospital   (Malawi)

^d OXFORD EYE HOSPITAL   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f HERIOT WATT UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOPSY TECHNIQUE; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; KERATINIZATION; MAJOR CLINICAL STUDY; MALAWI; MALE; OCULAR SURFACE SQUAMOUS NEOPLASIA; PRIORITY JOURNAL; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; TUMOR INVASION; TUMOR VOLUME;

CONJUNCTIVA; NEOPLASIA;

ADULT; BIOPSY; CARCINOMA, SQUAMOUS CELL; CONJUNCTIVAL NEOPLASMS; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALAWI; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84880002788     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-302533     Document Type: Article

References (15)

1. Saornil MA, Becerra E, Mendez MC, et al. [Conjunctival tumors].Tumores de la conjuntiva. Arch Soc Esp Oftalmol 2009;84:7-22.
2. Waddell KM, Lewallen S, Lucas SB, et al. Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br J Ophthalmol 1996;80:503-8. (Pubitemid 26187086)
3. Furahini G, Lewallen S. Epidemiology and management of ocular surface squamous neoplasia in Tanzania. Ophthalmic Epidemiol 2010;17:171-6.
4. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol 1995;39:429-50.
5. Makupa II, Swai B, Makupa WU, et al. Clinical factors associated with malignancy and HIV status in patients with ocular surface squamous neoplasia at Kilimanjaro Christian Medical Centre, Tanzania. Br J Ophthalmol 2012;96:482-4.
6. Karp CL, Galor A, Chhabra S, et al. Subconjunctival/perilesional recombinant interferon alpha2b for ocular surface squamous neoplasia: a 10-year review. Ophthalmology 2010;117:2241-6.
7. Gupta A, Muecke J. Treatment of ocular surface squamous neoplasia with Mitomycin C. Br J Ophthalmol 2010;94:555-8.
8. Parrozzani R, Lazzarini D, Alemany-Rubio E, et al. Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study. Br J Ophthalmol 2011;95:355-9.
9. International MRG. World directory of minorities and indigenous peoples Overview. Malawi: 2007.
10. Magidson J. Correlated component regression: a prediction/classification methodology for possibly many features. Proceedings of the American Statistical Association. Alexandria, Virginia, USA: Statistical Innovations Inc., 2010.
11. Newton R, Ziegler J, Ateenyi-Agaba C, et al. The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br J Cancer 2002;87:301-8.
12. Waddell K, Kwehangana J, Johnston WT, et al . A case-control study of ocular surface squamous neoplasia (OSSN) in Uganda. Int J Cancer 2010;127:427-32.
13. Kaimbo Wa Kaimbo D, Parys-Van Ginderdeuren R, Missotten L. Conjunctival squamous cell carcinoma and intraepithelial neoplasia in AIDS patients in Congo Kinshasa. Bull Soc Belge Ophtalmol 1998;268:135-41.
14. UNAIDS. Malawi AIDS info, 2009.
15. Farasat S, Yu SS, Neel VA, et al. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011;64:1051-9.